Recent Advances in Multiple Myeloma: Applying Real-World Evidence to Clinical Practice - Episode 9

Comparing Combination Treatment Regimens in Transplant-Eligible NDMM


Matthew James Pianko, MD, provides an overview of the recently updated data from the GRIFFIN trial and the role of quadruplet versus triplet regimens in the treatment landscape of transplant-eligible newly diagnosed multiple myeloma.